Mr. Carlisle has more than 17 years of experience in the medical device industry, according to a July 22 news release. He previously worked with Integra LifeSciences and Perma Pure. He also held a position on NovaBone’s board of directors for 10 months.
NovaBone is based in Alachua, Fla., and is behind the first orthopedic bioactive synthetic bone graft, according to the company.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
